Dr. Richburg's research focuses on characterizing the molecular and cellular mechanisms that initiate testicular germ cells to undergo apoptosis after injury by environmental or chemotherapeutic agents.

Marinelli's lab focuses on understanding the biological bases of addiction. The lab uses a systems-approach, combining complementary
levels of analysis, which include molecular, cellular, anatomical, and behavioral studies.

Morrisett's primary research interests center upon the role of amino-acid derived neurotransmitter systems and synaptic transmission in alterations that in underlie a variety of forms of neural functioning and pathologies.

Vasquez' research efforts are focused in the areas of genome instability, DNA damage and mechanisms of repair. A unique feature of this lab's approach is an emphasis on the role of DNA structure in human disease, particularly on cancer-relevant chromosomal translocations, and the development of novel therapeutic strategies for treating cancer.

Ponomarev's research focuses on two related questions: a) molecular mechanisms of alcohol addiction and b) molecular mechanisms of brain plasticity in response to genetic and pharmacological perturbations.

Wang's research activity is focused on understanding the effects of DNA modification and secondary structure on DNA damage/repair and genomic instability, and the cellular response to DNA damaging agents.

Parkinson Gene Link May Aid Battle Against Disease

Dr. Som Mukhopad-hyay led the research team that focused on the gene SLC30A10 and its role as a "door opener" in
helping to remove elevated levels of manganese from cells. The study was published in the Oct. 15, 2014 issue of The Journal of Neuroscience.

Erickson Authors New Book

"Drugs, the Brain and Behavior" is co-authored by Dr. Carlton Erickson, the college's associate dean for research and graduate studies,
and Dr. John Brick, executive director of Intoxikon International.